Mason is slated to retire Oct. 31; Serbousek, a 30-year medtech veteran with stints at Biomet, Medtronic (NYSE:MDT) and Johnson & Johnson (NYSE:JNJ) unit DePuy Orthopaedics, is due to take over the corner office the next day.
“Jon’s expertise and proven track record are perfectly aligned with our business composition and make him an exceptional choice to lead the company as President and CEO,” Mason said in prepared remarks. “With the recent leadership change in our spine business, I am pleased that Jon has agreed to serve as the president of global spine on an interim basis. This will give him time to focus on our needs and opportunities in that business before he takes on the broader CEO role, which should help ensure a seamless leadership transition for the benefit of all Orthofix stakeholders.”
“I am excited to join Orthofix,” Serbousek added. “It is an honor to assume this leadership role, particularly at a time when the company is so well positioned for future shareholder value creation. I look forward to working with the great team at Orthofix as we continue to shape the company for the years ahead.”
Ra Medical ousts CEO Irwin
Ra Medical (NYSE:RMED) yesterday ousted chairman, CEO, co-president & CTO Dean Irwin without cause. The excimer laser system maker named CFO Andrew Jackson as interim CEO while it seeks a permanent replacement for Irwin. Martin Colombatto was named chairman.
“On behalf of the entire Ra Medical board, I want to thank Dean for his contributions and for his years of service to Ra Medical. The board is focused on finding a CEO who can guide us through the next phase of commercialization and growth,” Colombatto said.
Corinth Medical taps Duddy for CEO
Fresh off of a $12 million funding round for its Velonion urology device, Corinth Medical today named Steven Duddy to replace founder Csaba Truckai as president & CEO.
“Steve brings an exemplary track record of executive skills combined with business vision gained through his global leadership in the medical device arena,” Truckai said in prepared remarks. “His success in developing go-to-market commercialization strategies will be invaluable to the company and make him an excellent fit for the position and the organization.”
“This is a very exciting time for Corinth MedTech and its Veloxion System, which has a strong intellectual property position and tremendous potential to improve patient health. I am honored to lead the company and look forward to the opportunity to build a powerful commercial brand,” Duddy added.
CeloNova BioSciences names ex-Tryton chief St. Bernard as CEO
CeloNova BioSciences last week named former Tryton Medical chief executive Carl St. Bernard to be its new president & CEO.
St. Bernard replaces two-year interim chief Jason Cone, who was named to a seat on CeloNova’s board.
- Virginia Bio taps Newby II as CEO
- On Target Labs lures ex-Philips exec Barys for CEO
- ReShape Lifesciences CFO Youngstrom to resign
- Stryker retools, names Stiles as ortho & spine prez, Pierce as medsurg & neurotech prez, joint prez Simpson departs
- Accuray commercial chief Hadjadjeba to depart
- Gates Foundation lures Apple Health exec Trister
- MiMedx GC & secretary Haden resigns
- Second Sight Medical hires three VPs
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!